{
    "2019-05-23": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Earnings Preview: Veeva (VEEV), Palo Alto Networks (PANW), Workday (WDAY)",
                "features": {
                    "keywords": [
                        "earnings preview",
                        "Veeva",
                        "Palo Alto Networks",
                        "Workday"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "software"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Amgen (AMGN) Offers to Acquire Drug Discovery Platform",
                "features": {
                    "keywords": [
                        "Amgen",
                        "acquisition",
                        "drug discovery"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Lilly (LLY) Launches Half-Priced Version of Humalog Insulin",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Humalog",
                        "insulin pricing"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "J&J's Invokana sNDA Gets Priority Review Status From FDA",
                "features": {
                    "keywords": [
                        "J&J",
                        "Invokana",
                        "FDA priority review"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}